Prevention and Treatment of Atherosclerosis
Improving State-of-the-Art Management and Search for Novel Targets
Prevention and Treatment of Atherosclerosis
Improving State-of-the-Art Management and Search for Novel Targets
This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets.
Diet, Life Style, Smoking
Blood Pressure LoweringGlycemic Control in Diabetes
LDL-Cholesterol Lowering
Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation)
Triglyceride Rich Lipoproteins
HDL
Lipoprotein(a)
Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome
Nutraceuticals / Functional Food
Adipose Tissue (WAT, BAT)
Microbiota and Cardiometabolic Disease
SMCs, Matrix
Immune Modulation
NETs and Neutrophils
Genomic Strategies Towards Identification of Novel Therapeutic Targets
Non Coding RNAs
Metabolomics, Lipidomics
Epigenomics.
Eckardstein, Arnold von
Binder, Christoph J.
ISBN | 978-3-030-86075-2 |
---|---|
Artikelnummer | 9783030860752 |
Medientyp | Buch |
Auflage | 1st ed. 2022 |
Copyrightjahr | 2022 |
Verlag | Springer, Berlin |
Umfang | X, 538 Seiten |
Abbildungen | X, 538 p. 40 illus., 37 illus. in color. |
Sprache | Englisch |